Kartesia provides financing to support the fast development of OMX Group

Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, is pleased to announce that it has provided a unitranche financing to support OMX Group (“OMX” or “the Group”) in its next phase of growth in Europe.

Founded in 2023 by Thomas Ringeisen and Léo Spector, OMX is a leading French distributor of specialized medical devices and provider of value-added solutions. Backed by Entrepreneur Invest as a minority investor since inception, the Group has been a pioneer in consolidating the fragmented French specialized healthcare distribution market, benefiting from a strong first-mover advantage, with nine acquisitions completed to date.

OMX has developed a unique multi-specialist platform spanning seven therapeutic areas: imaging and radiotherapy, ear-nose-throat, ophthalmology, physiotherapy, medical aesthetics, defibrillation and home care. It combines the sale of high-quality medical equipment – sourced from world-leading OEMs, with value-added services such as installation, maintenance, training and regulatory support. OMX serves over 20,000 clients including hospitals, clinics, practitioners and elderly care facilities.

This unitranche financing was deployed from Kartesia’s Senior Opportunities (“KSO”) strategy. The proceeds will be used to refinance part of the Group’s indebtedness and to support its ongoing buy-and-build strategy in France and across Europe.

The deal team at Kartesia comprised Charles-Henri Clappier, Alexis Midol and Antonin Ramon.

Alexis Midol, Associate Director at Kartesia, commented: “We are thrilled to be part of OMX’s growth journey. Thanks to its strong expertise in the French medical distribution market, its longstanding OEM partnerships and its customer-centric approach, OMX has established itself as a trusted route-to-market partner in highly specialized and niche healthcare segments. With Kartesia’s support, the Group is well positioned to scale the platform and capture further opportunities in a growing and evolving market.”